Regeneron to acquire decibel therapeutics, strengthening gene therapy and hearing loss programs

Proposed acquisition builds on existing collaboration between decibel and regeneron, will accelerate and further resource key gene therapy programs for hearing loss

REGN Ratings Summary

REGN Quant Ranking